ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Begins Practice Certification Program

June 5, 2009

NCAB Approves CIS Recompetition, Restructuring

May 17, 1991

In Brief: David Sundial Named Health Director Of Senate Labor & Human Resources Committee’s HHS Office

September 20, 1985

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012